MD, PhD, FRACS
Austin health, University of Melbourne
“The role of cannabinoids in the treatment of pancreatic cancer”
Background: Advanced and minimally invasive liver, pancreatic and biliary surgeon with a focus on pancreatic cancer research. Laboratory head of pancreatic cancer biology group. Clinical research: Advanced and minimally invasive pancreatic resection techniques. Borderline resectable pancreatic cancers. Neoadjuvant and adjuvant chemotherapy trials. Brachytherapy for treatment of pancreatic cancer. Enhanced post -operative recovery techniques. Fluid sparing therapies in pancreatic surgery. Familial pancreatic cancer screening.
Basic Research: Mouse models of pancreatic cancer. K-ras targeted therapies. Role of P-21 Kinase in the development and progression of pancreatic cancer. Novel therapies for the treatment of pancreatic cancer including use of Cannabis
Contribution to the field of research: I have over 150 peer-reviewed publications. I have written one book and have contributed 4 book chapters in leading surgical texts. I have publications in the highest ranked surgical journals that include Annals of Surgery, British Journal of Surgery, World Journal of Surgery and Annals of Surgical Oncology. I have co-authored five publications in Nature and two in Cancer Letters. I have had 40+ international presentations and 2000+ listed citations relating to my published work. I am a member of Victorian Integrated Cancer Services, Cancer Council and Victorian State Government committees developing guidelines to improve patient outcomes with pancreatic cancer.